- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 02:30 | Rakovina Therapeutics Inc (2): Rakovina shareholders elect five directors at AGM | 1 | Stockwatch | ||
| RAKOVINA THERAPEUTICS Aktie jetzt für 0€ handeln | |||||
| 00:24 | Rakovina Therapeutics Inc: Rakovina Therapeutics Announces Results from 2025 Annual General Meeting | 34 | GlobeNewswire (Europe) | VANCOUVER, British Columbia, June 25, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO0) ("Rakovina" or the "Company"), a biopharmaceutical company advancing next-generation... ► Artikel lesen | |
| Di | XFRA NEW INSTRUMENTS AVAILABLE ON 24.06.2025 | 371 | Xetra Newsboard | The following instruments on XETRA do have their first trading 24.06.2025 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 24.06.2025
Aktien
1 NL0015002J37 JBS N.V.
2 AU0000400616... ► Artikel lesen | |
| Mo | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 23.06.2025 | 437 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 23.06.2025Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 23.06.2025ISIN NameCA39261L2049 GREEN... ► Artikel lesen | |
| Mo | XFRA ISIN CHANGE | 389 | Xetra Newsboard | Einstellung Aufnahme ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: AnmerkungenCA39261L2049 Green Battery Minerals Inc. 23.06.2025 CA3194101067 First Canadian Grahite Inc. 24.06.2025 Tausch 1:1US15117F8077 Cellectar... ► Artikel lesen | |
| Sa | Rakovina Therapeutics Inc (1): Rakovina $1.35-million debenture private placement | 3 | Stockwatch | ||
| Sa | Rakovina Therapeutics Inc (1): Rakovina 93-million-share private placement | 1 | Stockwatch | ||
| Sa | Rakovina Therapeutics Inc (1): Rakovina Therapeutics 1:10 rollback | 2 | Stockwatch | ||
| Fr | Rakovina Therapeutics Inc (1): Rakovina to roll back shares 1:10 effective June 24 | 5 | Stockwatch | ||
| Fr | Rakovina Therapeutics Inc: Rakovina Therapeutics Announces Share Consolidation Effective Date | 194 | GlobeNewswire (Europe) | VANCOUVER, British Columbia, June 20, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE:7JO) ("Rakovina" or the "Company") is pleased to announce that the effective date for the... ► Artikel lesen | |
| 12.06. | Rakovina Therapeutics Inc: Rakovina Therapeutics to Attend BIO International Convention to Advance Strategic Partnering Opportunities | 1 | GlobeNewswire (USA) | ||
| 06.06. | Rakovina Therapeutics Inc: Rakovina Therapeutics completes $4.9M financing | 1 | Stockwatch | ||
| 06.06. | Rakovina Therapeutics Inc: Rakovina Therapeutics Announces the Closing of Oversubscribed Private Placement of $4.9 Million | 112 | GlobeNewswire (Europe) | VANCOUVER, British Columbia, June 06, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO) ("Rakovina" or the "Company"), a biopharmaceutical company advancing innovative cancer... ► Artikel lesen | |
| 02.06. | Rakovina Therapeutics reports Q1 results | 1 | Seeking Alpha | ||
| 02.06. | Rakovina Therapeutics Inc: Rakovina Therapeutics Announces 2025 Q1 Financial Results and Provides Corporate Update | 129 | GlobeNewswire (Europe) | VANCOUVER, British Columbia, June 02, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO) ("Rakovina" or the "Company"), a biopharmaceutical company advancing novel DNA-damage... ► Artikel lesen | |
| 29.05. | Rakovina Therapeutics Inc: Rakovina to issue shares to some debenture holders | 1 | Stockwatch | ||
| 29.05. | Rakovina Therapeutics Inc: Rakovina Announces Debentureholder Election to Receive Shares in Partial Satisfaction of Debenture Interest Payment Obligations | 86 | GlobeNewswire (Europe) | VANCOUVER, British Columbia, May 28, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO) ("Rakovina" or the "Company") announces that in accordance with the terms of an indenture... ► Artikel lesen | |
| 16.05. | Rakovina Therapeutics Inc: Rakovina Therapeutics arranges $4-million financing | 1 | Stockwatch | ||
| 15.05. | Rakovina Therapeutics announces financing, share consolidation | 2 | Seeking Alpha | ||
| 15.05. | Rakovina Therapeutics Inc: Rakovina Therapeutics Announces Strategic Private Placement, Convertible Debt Financing, and Share Consolidation to Accelerate US-Focused Growth and AI-Powered Oncology Innovation | 68 | GlobeNewswire (Europe) | VANCOUVER, British Columbia, May 15, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO) ("Rakovina" or the "Company"), a biopharmaceutical company advancing innovative cancer... ► Artikel lesen |
1 2 3 Weiter >>
49 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| QIAGEN | 41,230 | +2,74 % | Biotech Report: Evotec rutschen ab, auch Qiagen verlieren | (shareribs.com) Frankfurt 19.06.2025 - Biotech-Aktien bewegen sich im deutschen Handel überwiegend nach unten. Evotec korrigieren dabei um mehr als drei Prozent. An der Wall Street findet wegen eines... ► Artikel lesen | |
| VOR BIOPHARMA | 1,030 | +88,47 % | Pre-market Movers: Vor Biopharma, Worthington Steel, Surf Air Mobility, Nano Labs, Protagenic Therapeutics | BEIJING (dpa-AFX) - The following are some of the stocks making big moves in Thursday's pre-market trading (as of 07.30 A.M. ET).In the Green Vor Biopharma Inc. (VOR) is up over 109% at $1.16.
Worthington... ► Artikel lesen | |
| EVOTEC | 7,196 | +0,50 % | Evotec-Aktie: Hop oder Top?! | © Foto: Symbolbild von Pilan FilmesDie Evotec-Aktie sorgt für Kopfschmerzen bei Anlegern. Nach einer kräftigen Erholung im Frühjahr zeigt sich das Papier des Hamburger Wirkstoffforschers wieder von... ► Artikel lesen | |
| SPRINGWORKS THERAPEUTICS | 46,990 | +0,04 % | SpringWorks Therapeutics, Inc.: SpringWorks Therapeutics Receives Positive CHMP Opinion for Nirogacestat for the Treatment of Adults with Desmoid Tumors | - If approved, nirogacestat will be the first and only therapy with marketing authorization in the EU for the treatment of desmoid tumors -
- Decision from European Commission expected in the third... ► Artikel lesen | |
| BIONTECH | 90,80 | +1,11 % | Kursfantasie durch Drohnen und Künstliche Intelligenz: Rheinmetall, BioNTech, NetraMark Aktie | Drohnen und Künstliche Intelligenz werden ganze Branchen revolutionieren. Börsennotierte Unternehmen, die dabei vorne mitspielt, haben Kursfantasie. So wie NetraMark. Mit Künstlicher Intelligenz helfen... ► Artikel lesen | |
| RECURSION PHARMACEUTICALS | 5,295 | +2,72 % | Recursion Pharmaceuticals: Recursion Reports First Quarter 2025 Financial Results and Provides Business Update | Pipeline: Delivered on our commitment to a more focused R&D strategy by advancing a streamlined portfolio of 5+ clinical and preclinical programs in oncology and rare disease, while deprioritizing... ► Artikel lesen | |
| KYMERA THERAPEUTICS | 45,130 | -2,88 % | Gilead Sciences Partners Kymera Therapeutics To Develop Novel Oral Molecular Glue CDK2 Degraders | FOSTER CITY (dpa-AFX) - Gilead Sciences, Inc. (GILD) and Kymera Therapeutics, Inc. (KYMR) announced Wednesday that they have entered into an exclusive option and license agreement to accelerate... ► Artikel lesen | |
| EDGEWISE THERAPEUTICS | 13,020 | -9,27 % | Edgewise Therapeutics Reports Positive Results on Sevasemten Program for Becker and Duchenne Muscular Dystrophies | - New open label data in Becker demonstrated sustained disease stabilization up to three years, reinforcing prior clinical findings -- Ongoing pivotal trial and FDA Type C meeting provide... ► Artikel lesen | |
| SUMMIT THERAPEUTICS | 21,210 | -0,45 % | H.C. Wainwright Sticks With Bullish Call on Summit Therapeutics, $44 Target | ||
| CUREVAC | 4,578 | -1,46 % | EQS-News: CureVac Announces Voting Results of General Meeting | Emittent / Herausgeber: CureVac
/ Schlagwort(e): Hauptversammlung
CureVac Announces Voting Results of General Meeting
24.06.2025 / 22:09 CET/CEST
Für den Inhalt der... ► Artikel lesen | |
| REGENCELL BIOSCIENCE | 20,330 | -6,57 % | Tesla, Regencell lead market cap stock movers this Monday | ||
| INSTIL BIO | 22,470 | -16,50 % | Instil Bio Announces Appointment of Jamie Freedman, M.D., Ph.D., as Chief Medical Officer | DALLAS, June 02, 2025 (GLOBE NEWSWIRE) -- Instil Bio, Inc. ("Instil") (Nasdaq: TIL), a clinical-stage biopharmaceutical company focused on developing a pipeline of novel cancer therapies, today announced... ► Artikel lesen | |
| ADMA BIOLOGICS | 18,310 | +4,03 % | ADMA vs Takeda: Which Plasma Therapy Stock Is the Better Buy Today? | ||
| VERVE THERAPEUTICS | 11,230 | +0,18 % | Lilly To Acquire Verve Therapeutics For One-Time Cardiovascular Treatments | ||
| VERA THERAPEUTICS | 23,130 | -0,84 % | Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | BRISBANE, Calif., June 09, 2025 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that on June 3, 2025, the Compensation Committee granted inducement awards consisting of... ► Artikel lesen |
Das Unternehmen RAKOVINA THERAPEUTICS INC kann der Branche Biotechnologie zugeordnet werden. Der aktuelle Kurs liegt bei 0,400 Euro und damit -7,62 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu RAKOVINA THERAPEUTICS INC finden Sie auf Wallstreet Online.